Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).

Margolin KA, Moon J, Flaherty LE, Lao CD, Akerley WL, Othus M, Sosman JA, Kirkwood JM, Sondak VK
Clin Cancer Res. 2012 18 (4): 1129-37

PMID: 22228638 · PMCID: PMC3481165 · DOI:10.1158/1078-0432.CCR-11-2488

MeSH Terms (20)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Benzenesulfonates Female Humans Male Melanoma Middle Aged Neoplasm Metastasis Neoplasm Staging Niacinamide Phenylurea Compounds Pyridines Quinolones Sirolimus Sorafenib Survival Analysis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links